Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...
A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...
Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research ...
in a single inhaler, the Ellipta. Sales of the drug are starting to pick up since its slow start in 2013, and in Q1 the drug recorded revenues of £204million ($264m), up 84% on the same period ...
1d
ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.
The rising prevalence of respiratory diseases and technological advancements drive significant market growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aerosol Drug Delivery Devices Market Size & Growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback